Robb Knie is the President and CEO of Hoth Therapeutics, a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet.
Robb Knie is the President and CEO of Hoth Therapeutics, a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. He has served in this role since May 2017. Mr. Knie has over 20 years of equity markets experience and has been featured in Bloomberg, The Wall Street Journal, and Forbes Magazine as an Independent Equity Analyst.
Full founder directory · Investor directory · Company funding database · Fundraising library